首页> 中文期刊>疑难病杂志 >血清FABP4、FGF21、Nesfatin-1与妊娠糖尿病患者胰岛素抵抗的关系

血清FABP4、FGF21、Nesfatin-1与妊娠糖尿病患者胰岛素抵抗的关系

     

摘要

Objective To investigate the relationship between the fatty acid binding protein 4 (FABP4), fibroblast growth factor 21 (FGF21), food intake inhibitor 1 (Nesfatin-1) and insulin resistance (IR) in patients with gestational diabe-tes mellitus (GDM).Methods Sixty GDM patients and thirty healthy cases were enrolled in this study.The serum levels of FABP4, FGF21, Nesfatin-1 and index of IR were measured and analyzed.Results GDM group serum FABP4, FGF21, Nes-fatin-1 levels were significantly higher[FABP4: (27.49 ±3.72) μg/L vs.(18.98 ±5.51) μg /L, t =2.585, P <0.05;FGF21 :(198.14 ±13.53) ng/L vs.(102.4 ±19.7) ng /L, t =2.137, P <0.05; Nesfatin-1: (2.49 ±0.72) μg/L vs. (1.98 ±0.51) μg /L, t =2.361, P <0.05〗.GDM patients HOMA-IR, HOMA-β, PGAUC, INSAUC /PGAUC, △I30 /△G30 levels were significantly higher ( HOMA-IR: 3.89 ±1.12 vs.2.05 ±0.54, t =2.362, P <0.05; HOMA-β:112.63 ±29.52 vs.169.72 ±42.14, t =2.809, P <0.05; PGAUC: 20.55 ±2.21 vs.13.98 ±1.66, t =2.697, P <0.05; INSAUC /PGAUC: 8.23 ±3.12 vs.10.92 ±2.91, t =2.133, P <0.05; △ I30 /△ G30:15.66 ±5.49 vs.22.12 ± 3.34, t =2.249, P <0.05).FABP4, FGF21, Nesfatin-1 was positively correlated with HOMA-IR ( r =0.402, 0.374, 0.398, P <0.05), and HOMA-βnegative correlation ( r =-0.435, -0.335, -0.376, P <0.05).Conclusion The ser-um levels of FABP4, FGF21, Nesfatin-1 were significantly increased in GDM patients, and there was a certain correlation be-tween and IR.%目的:探讨脂肪酸结合蛋白4(FABP4)、成纤维细胞生长因子21(FGF21)、摄食抑制因子-1(Nesfatin-1)与妊娠糖尿病(GDM)患者胰岛素抵抗(IR)的关系。方法选取2013年1月—2015年12月胶州中心医院妇产科收治的60例 GDM 患者(GDM 组)和30例健康孕妇(对照组)为研究对象,检测血清 FABP4、FGF21、Nesfatin-1水平和IR 相关指数,并分析比较它们之间的关系。结果GDM 组患者血清 FABP4、FGF21、Nesfatin-1水平均明显高于对照组[FABP4(27.49±3.72)μg/L vs.(18.98±5.51)μg/L, t =2.585, P <0.05;FGF21:(198.14±13.53) ng/L vs.(102.4±19.7) ng/L, t =2.137, P <0.05;Nesfatin-1(2.49±0.72)μg/L vs.(1.98±0.51)μg/L, t =2.361, P <0.05]。GDM 组患者 HOMA-IR、 HOMA-β、PGAUC、INSAUC/PGAUC、△I30/△G30水平均明显高于对照组(HOMA-IR 3.89±1.12 vs.2.05±0.54, t =2.362, P <0.05;HOMA-β112.63±29.52 vs.169.72±42.14, t =2.809, P <0.05;PGAUC 20.55±2.21 vs.13.98±1.66, t =2.697, P <0.05;INSAUC/PGAUC 8.23±3.12 vs.10.92±2.91, t =2.133, P <0.05;△I30/△G3015.66±5.49 vs.22.12±3.34, t =2.249, P <0.05)。 FABP4、FGF21、Nesfatin-1与 HO-MA-IR 呈正相关( r =0.402、0.374、0.398, P <0.05),与 HOMA-β呈负相关( r =-0.435、-0.335、-0.376, P <0.05)。结论GDM 患者血清 FABP4、FGF21、Nesfatin-1水平明显上升,且与 IR 存在一定的相关性。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号